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Abstract
Mucocutaneous leishmaniasis is caused by infections with intracellular parasites of the
Leishmania Viannia subgenus, including Leishmania guyanensis. The pathology develops after
parasite dissemination to nasopharyngeal tissues, where destructive metastatic lesions form with
chronic inflammation. Currently, the mechanisms involved in lesion development are poorly
understood. Here we show that metastasizing parasites have a high Leishmania RNA virus–1
(LRV1) burden that is recognized by the host Toll-like receptor 3 (TLR3) to induce
proinflammatory cytokines and chemokines. Paradoxically, these TLR3-mediated immune
responses rendered mice more susceptible to infection, and the animals developed an increased
footpad swelling and parasitemia. Thus, LRV1 in the metastasizing parasites subverted the host
immune response to Leishmania and promoted parasite persistence.
Leishmania parasites are obligate intracellular protozoan parasites transmitted to the
mammalian host by the bite of an infected sand fly, where they predominantly infect
macrophages. In Latin America, leishmaniasis caused by the Leishmania Viannia
(L.Viannia) subgenus is endemic, causing cutaneous (CL) and mucocutaneous (MCL)
leishmaniasis (1). Clinical MCL involves parasitic dissemination to the nasopharyngeal
areas of the face, leading to destructive metastatic secondary lesions and hyperinflammatory
immune responses (2–4). About 5 to 10% of individuals asymptomatic or with resolved CL
lesions may develop MCL (1, 5, 6).
MCL development is associated with persistent immune responses showing
proinflammatory mediator expression with high tumor necrosis factor α (TNF-α), CXCL10,
and CCL4; a mixed intralesional T helper 1 (TH1)/TH2 phenotype; and elevated cytotoxic T
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cell activity (7–10). In addition to parasite-derived virulence factors, host genetics [such as
polymorphisms for TNF-α and interleukin-6 (IL-6)] and immune status appear to influence
MCL development (11, 12).
Hamsters infected with L.Viannia parasites isolated from human MCL lesions reproduce the
metastatic phenotype with primary and secondary lesion development (13). Using this
model, we characterized clones derived from the metastasizing L.guyanensis WHI/BR/78/
M5313-L.g.M5313(M+) strain as metastatic (L.g.M+) or nonmetastatic (L.g.M−) after
infection, depending on their ability to reproducibly develop secondary metastatic lesions
(14). Previously, we showed that L.g.M+ clones derived from L.g.M5313 were more
resistant to oxidative stress than L.g.M− clones and persisted in activated murine bone-
marrow–derived macrophages despite their elevated nitric oxide levels (15).
On the basis of these observations, we hypothesized that Lg.M+ and L.g.M− parasites
differentially modulate the host macrophage responses. Using DNA microarrays, we
identified differential gene expression between uninfected macrophages and L.g.M+(1672)
or L.g.M−(1513) infected macrophages, and L.g.M− directly compared to L.g.M+ (294)
infected macrophages. Statistical significance was determined at ≥1.5-fold, P ≤ 0.05. We
focused on genes involved in the immune response because of their relevance in MCL
pathology.
In vitro, infected macrophages expressed significantly greater amounts of chemokines and
cytokines CCL5, CXCL10, TNF-α, and IL-6 after infection with L.g.M+ parasites compared
with L.g.M− parasites or L. major LV39 (Fig. 1, A and B) (16). We observed similar
increased cytokine and chemokine expression after infection with L.g. from human MCL
lesions (h-MCL-Lg1398) as compared to cytokine and chemokine expression during L.g.
infection from human CL lesions (h-CL-Lg1881) (Fig. 1C). Thus, the elevated cytokine and
chemokine levels after macrophage infection are associated with metastasizing parasites.
Leishmania parasites enter the macrophage endosomal compartment and form a
phagolysosome (17). Pretreatment of macrophages with chloroquine, which induces
vacuolar alkanization and impairs recognition of pathogen-derived motifs by cells (18), or
cytochalasin D, which inhibits parasite phagocytosis by inhibiting actin polymerization (19),
showed that L.g.M+ parasite-dependent induction of proinflammatory mediator required
parasite entry into the cell and sequestration into a mature phagolysosome (fig. S1A).
Therefore, we investigated the role of the macrophage endosomal Toll-like receptors (TLRs)
of the myeloid differentiation factor 88 (MyD88) (TLR7 and TLR9) and/or of the TIR
domain–containing adapter-inducing interferon-β (TRIF)-dependent pathways (TLR3).
Using macrophage functionally deficient for TLR3, 7, or 9, or for the adaptors MyD88 and
TRIF, we found that the TLR3-TRIF– dependent pathway was essential for increased
proinflammatory mediator expression after macrophage infection with L.g.M+ (Fig. 2 and
fig. S1B). In addition, MyD88-dependent TLR7 activation within the macrophage was
required for maximal secretion of the proinflammatory mediators after infection with M+
parasites (Fig. 2 and fig. S1B). In our system, TLR9 was not involved in L.g.M+-dependent
macrophage responses, suggesting that recognition of Leishmania-derived DNA motifs by
the host’s TLR9 does not differ between the Leishmania strains (Fig. 2A).
In other murine models of infection, TLR3 ligation up-regulates proinflammatory mediators
(TNF-α, IL-6, and chemokines) and type I interferons, resulting in organ damage (20–22).
To confirm the role of TLR3 in the recognition of L.g.M+ parasites, we analyzed IFN-β
expression. Infection with L.g.M+ induced significantly more IFN-β transcripts (31.14 ±
23.46) than L.g.M− clones (5.83 ± 4.27) after 6 hours by comparison with unstimulated
macrophage controls. This increase was observed as early as 2 hours after infection (Fig.
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2B). At the protein level, after macrophage infection, L.g.M+ M5313-derived and h-MCL
induced higher IFN-β secretion than L.g.M− parasites or h-CL parasites (Fig. 2C).
Furthermore, this expression was TLR3-TRIF dependent, with the MyD88 signaling
pathway augmenting secretion (Fig. 2C).
Endosomal TLRs recognize nucleic acid motifs, with TLR7 and TLR3 recognizing single-
stranded RNA (ssRNA) and double-stranded RNA (dsRNA), respectively (23). Our
experimental evidence suggested that nucleic acid–derived motifs were involved in the host
macrophage response to infection with metastasizing L.g. parasites. We observed increased
production of CCL5, TNF-α, and IL-6 in macrophages exposed to single-stranded
ribonuclease (ssRNAse)– and deoxyribonuclease (DNAse)–treated nucleic acids derived
from L.g.M+ parasites, compared with L.g.M− and L.major LV39 (fig. S2). Although not
statistically significant, these results suggested that the nucleic acid motif is resistant to
ssRNAse and DNAse treatments and is likely to be dsRNA.
L.Viannia parasites, including L.g.M5313(M+) and L. guyanensis and L. braziliensis MCL
human isolates, harbor the dsRNA Leishmania RNA virus 1 (LRV1) (24–26). These viruses
have a capsid coat protecting a 5.3-kb dsRNA genome (27). Metastasizing promastigotes
had greater levels of LRV1 (L.g.M+ or h-MCL-LRVhigh) than nonmetastasizing
promastigotes (L.g.M− or h-CL-LRVlow) as shown by the presence of a ~5.3-kb, DNAse-
insensitive, RNAse III–sensitive band in agarose gels, and LRV1 quantification by
quantitative reverse transcriptase–polymerase chain reaction (qRT-PCR) (Fig. 3, A to C, and
fig. S3A).We thus verified that macrophages treated with purified LRV1 dsRNA (fig. S3)
induced a phenotype similar to that of macrophage infected with metastasizing parasites, and
as shown by an increased expression of CXCL10, CCL5, TNF-α, IL-6, and IFN-β
transcripts, this increase was TLR3 dependent (Fig. 3D). Because the L.g.M5313 M+ and M
− parasites were not isogenic, we performed new experiments with parasites derived from
the WHO reference strain L.g.M4147 that metastatizes in the hamster (28) and carries the
LRV1-4 virus (29). Macrophage infection with L.g.M4147-LRVhigh parasites produced
significantly greater amounts of cytokines and chemokines than infection with its respective
isogenic virus-free derivative L.g.M4147LRVneg, in a TLR3-dependent manner (Fig. 3E and
fig. S4) (30, 31). Similar parasite burdens were observed for all parasites infected into the
wild-type and the TLR-, TRIF-, and MyD88-deficient macrophages (table S1).
A role for TLR3 and LRV1 in leishmaniasis development was analyzed in vivo, with
TLR3−/−, TLR7−/−, and WT mice that were infected in the footpad. A significant decrease
in footpad swelling, and diminished parasite burden, were observed in TLR3−/− mice
infected with L.g.M+LRVhigh (M5313) or L.g.M4147-LRVhigh parasites compared with
wild-type mice (Fig. 4 and fig. S5). No consistent, significant decrease in disease pathology
was observed between TLR3−/− and wild-type mice infected with L.g.M–LRVlow (Lg17) or
L.g.M4147-LRVneg or between TLR7−/− and wild-type infected mice with the different
parasite isolates (Fig. 4 and Fig. S5). Further experimentation is required to elucidate the
role of TLR7-dependent immune responses with respect to infection with LRV1-containing
Leishmania parasites.
Our work showed that recognition of LRV1 within metastasizing L.g. parasites by the host
promoted inflammation and subverted the immune response to infection to promote parasite
persistence (2, 3, 32). Because recognition of LRV1 within the metastasizing L.g. parasites
arises early after infection, we hypothesize that LRV1 dsRNA is released from dead
parasites, unable to survive within the host macrophage. These results could open the door
to better diagnosis of risk for MCL disease and facilitate the development of new and more
efficient treatment regimes.
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Metastasizing L.g. parasites activate bone-marrow macrophages to elevate proinflammatory
cytokine and chemokine levels. (A) Transcript and (B and C) secreted protein levels induced
after C57BL/6 or BALB/c macrophage infection (ratio 1:10) with Leishmania parasites [two
L.g.M− clones (Lg03 and Lg17); two L.g.M+ clones (Lg13 and Lg21); L.g.M5313(M+);
L.g. derived from h-MCL (−L.g.1398) or hCL (L.g.1881) lesions; and L.major LV39] for 6
hours. Results were confirmed in several independent experiments (n > 3), and data reflect
mean ± SD transcript or protein increase relative to unstimulated controls. Significance was
determined at *P ≤ 0.05, and **P ≤ 0.01 for L.g.M+ or h-MCL versus L.g.M−, h-CL, and/or
L. major LV39-stimulated macrophages.
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L.g.M+ or h-MCL parasite-dependent induction of IFN-β and proinflammatory mediators by
macrophages uses TLR3 and TRIF. (A and C) Secreted protein and (B) transcript levels of
cytokines and chemokines induced after infection of macrophages (ratio 1:10) with
Leishmania parasites [two L.g.M+ clones (Lg13 and Lg21), two L.g.M− clones (Lg03 and
Lg17), and L.g.M5313(M+)] for 6 and 2 hours, respectively. Results were confirmed in
several independent experiments (n = 3), and data reflect mean ± SD transcript or protein
increase relative to unstimulated controls of L.g.M+ or L.g.M−. Significance was
determined between C57BL/6 and deficient macrophages (A and C) or between L.g.M+ or
h-MCL and L.g M− and h-CL parasites (B) at *P ≤ 0.05 and **P ≤ 0.01. n.i, not induced.
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High LRV1 burden within metastasizing L.g. promastigotes stimulates cytokine and
chemokine production in macrophages via TLR3. (A) ssRNAse-treated nucleic acids were
DNAse treated, and the 5.3-kb LRV1 dsRNA band visualized by gel electrophoresis. (B)
LRV1 virus burden within Leishmania parasites was assessed by qRT-PCR with LRV1 and
Leishmania Kmp11 gene primers; significance was determined between metastasizing
(L.g.M+ and h-MCL) versus nonmetastasizing (L.g.M− and h-CL) parasites. (C) Nucleic
acids from L.g.M5313(M+) promastigotes, pretreated with a ssRNA-specific RNAse, were
treated with DNAse or with the dsRNA-specific RNAse III and separated by gel
electrophoresis with the marker Lambda-DNA–Eco RI + Hind III (HindIII). (D)
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Macrophages were stimulated with purified LRV1 dsRNA (1 µg/ml) in endotoxin-free
(LAL) water, poly(I:C) (1 µg/ml), or lipopolysaccharide (LPS, 100 ng/ml) for 4 hours.
Transcript levels were assessed relative to unstimulated C57BL/6 macrophages by qRT-
PCR. Results are expressed as mean ± SD (n=2). (E) Protein abundance was quantified after
infection of macrophages (ratio 1:10) with L.g.M4147–LRVhigh (clones 2 and 3) or
L.g.M4147–LRVneg (clones 3 and 4) parasites after 6 hours. Controls: L.g.M− (Lg17),
L.g.M5313(M+), poly(I:C) (2 µg/ml), and LPS (100 ng/ml). Data reflect mean ± SD of
protein secretion relative to unstimulated controls (n = 2). Significance was determined at
*P ≤ 0.05 or **P ≤ 0.01.
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TLR3−/− mice infected with L.g.M+ parasites have decreased disease pathology when
compared to wild-type C57BL/6. Footpads (n ≥ 4) were infected with 3 × 106 parasites. (A)
Footpad swelling was measured weekly and (B) parasite burden (n=3) was determined at 4
weeks after infection by qRT-PCR with Leishmania Kmp11 gene-specific primers.
Representative data of two experiments, expressed as mean ± SEM of all mice infected per
group, with statistical significance at *P ≤ 0.05 and **P ≤ 0.01.
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Materials and Methods 
Mice strains 
5 to 6 week old C57BL/6 and BALB/c mice were purchased from Harlan 
Laboratories (Netherlands). MyD88-/-, TLR7-/-, and TLR9-/- mice were obtained 
Prof. S. Akira (Osaka University, Japan) via P. Launois (WHO-IRTC, Lausanne, 
Switzerland), or P. Romero (Ludwig Institute for Cancer, Lausanne, Switzerland) 
for TLR3-/- mice. TRIF∆LPS2 were obtained via B. Ryffel, (CNRS, Orléans, 
France)(32). The mice were bred and maintained at the animal facility of the 
Center of Immunity and Immunology, Lausanne (Switzerland) under pathogen 
free conditions. The mice and all experiments performed adhered to the guidelines 
set by the State Ethical Committee for the use of laboratory animals. All mutant 
and deficient mice were crossed onto a C57BL/6 background for at least eight 
generations.  
Parasite and cell culture 
L. guyanensis clones either non-metastatic (L.g.M-: Lg03, Lg17) or metastatic 
(L.g.M+: Lg13, Lg21) were derived from metastatic L. guyanensis M5313 
parasites (L.g.M5313(M+),WHI/BR/78/M5313) from CIDEIM (Centro 
Internacional de Entrenamiento e Investigaciones Médicas (14). Human isolates 
of L. guyanensis Lg1398 (MHOM/BR/1989/IM3597) and Lg1881 
(MHOM/BR/1992/IM3862) were obtained from the CLIOC (Coleção de 
Leishmania do Instituto Oswaldo Cruz, Brazil), and L. major LV39 
(MRHO/SU/59/P) and IR75 (MRHO/IR/75/ER) were obtained from WHO 
(World Health Organization). Parasites were cultured at 23oC in M199 medium 
(Gibco®) consisting of 10% FBS, 1% penicillin/streptomycin, and 5% Hepes 
(Sigma-Aldrich®), or on NNN media or grown in freshly prepared Schneider’s 
Insect Medium (Sigma-Aldrich) supplemented with 10% heat-inactivated fetal 
bovine serum, 2 mM L-glutamine, 1% penicillin/ streptomycin (Gibco®).  
The LRV-bearing strain of L. guyanensis M4147 (MHOM/BR/75/M4147- 
L.g.M4147-LRVhigh) and a virus free derivative (M4147/pX63-HYG-L.g.M4147-
LRVneg) expressing luciferase were described previously (29, 30). These lines 
contain the LUC gene integrated stably into the small subunit gene of the 
ribosomal RNA locus, yielding the LRV+ line M4147/SSU:IR2SAT-LUC(b) and 
the LRV- line M4147/pX63HYG/SSU:IR2SAT-LUC(b).  These parasites express 
high levels of luciferase (5 x 107 photons/sec/1 x 106 parasites, measured when 
cells were in logarithmic growth phase).  
In general, the parasites were maintained in culture for a maximum of 7 passages 
following either isolation from hamsters for all L. guyanensis M5313 derived 
parasites, from mouse footpads for L. major strains and L.g.M4147 strains, or 
after receipt from the collection banks. All mammalian cells were cultured in 
complete DMEM (Gibco®) with 10% FBS, 1% penicillin/streptomycin, and 1% 
Hepes (Sigma-Aldrich®).  
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Macrophage infection experiments 
Bone marrow cells were extracted from the femurs and tibias of naïve mice. The 
extracted cells were differentiated into bone marrow derived macrophages 
(BMMφ) for 5 days using complete DMEM supplemented with L929 conditioned 
media at 370C. Differentiated BMMφ were coated onto microtiter plates and 
infected (1:10) with stationary phase Leishmania parasites for 2, 6 or 24hrs. 
BMMφ were also stimulated with LPS (Sigma-Aldrich®), Poly I:C (Invivogen), 
or CpG (Invivogen) at 200 or 100ng/ml, 8 or 1 µg/ml and 5µM respectively or 
pretreated with Chloroquine (20µM), or Cytochalsin D (40µM), for 2 hours and 1 
hour respectively (Sigma-Aldrich®) (18, 33). Supernatants were collected and 
cells were lysed in RLT® (Qiagen) for RNA extraction. Infectivity of parasites 
was controlled by infection on culture slides stained with Diff-Quick® (Dade 
Behring) and the infectivity, and parasite burden of the different Leishmania 
parasites into BMMφ was calculated. Briefly, 750 BMMφ were counted in 3 
randomly selected microscope fields of view and the average percentage 
infectivity and number of infected BMMφ was calculated. 
DNA Microarray 
Three biologically independent experiments were performed. For each experiment 
transcript levels were compared from RNA preparations of uninfected BMMf’s or 
BMMf’s infected with either L.g. M+ (Lg13) or L.g. M-(Lg17) parasites. In 
addition, a dye-swap hybridization was performed for each comparison. RNA was 
purified by RNAeasy Mini Kit (Qiagen™), and the quality and quantity were 
verified by the Agilent Technologies (Germany) 2100 bioanalyzer and RNA 6000 
Nano Assay LabChip® kit. Mouse cDNA was produced and printed on glass-
slide microarrays by the DNA Array Facility Lausanne (DNA Array Facility 
Lausanne (DAFL), Switzerland). The 17k mouse cDNA microarray was made 
using the 15’000 gene clone set (NIA 15k cDNA set) available from the National 
Institute on Aging (NIA, USA). These cDNA clones are derived from embryonic 
and fetal mouse tissues. Additional 1400 cDNA clones were added from genes 
not contained in the NIA collection, containing both known genes and ESTs 
(GEO database: GSE21418). Briefly, cDNA was synthesized from 5 µg of RNA 
by direct incorporation of Cy3 or Cy5 fluorophore-labeled dCTP using random 
primers (Invitrogen) mediated by the Superscript II reverse transcriptase. For each 
labeling reaction, reference control RNA (2µl Alien spikes pool and 2µl 
Arabidopsis spikes pool obtained from the DAFL) was added for data 
normalization. The labeled probes were purified using the MiniElute PCR 
Purification kit (Qiagen), and mixed then concentrated using Millipore Microcon 
YM-30 columns. For hybridization, Cy3 and Cy5 labeled cDNA were mixed 
together, and loaded onto the glass-slides. Glass-slides were then scanned using 
an Agilent Technologies microarray scanner. The resulting TIF images were 
analyzed using GenePix Pro software (Axon Instruments, USA). Data analysis 
was performed using R statistics software (http://www.r-project.org/), Cy5 (red) 
and Cy3 (green) signal intensities were used to calculate M and A values for the 
array spots. Genes that were at least 1.5 fold over or under-expressed and with a 
p-value <0.05 were considered as differentially expressed. Statistical significance 
	   3	  
was calculated after standardization between the slides using the Limma statistical 
software package. Data analysis, quality assessment and normalization were 
performed by the DAFL. These resulting differentially expressed genes were then 
further analyzed using Ingenuity Pathways Analysis (Ingenuity® Systems, 
www.ingenuity.com).  
Isolation of RNA and cDNA Synthesis from macrophages for Real time PCR 
For all experiments, RNA was isolated with RNAeasy Mini Kit (Qiagen), and 
quantified by using a NanoDrop® ND-100 Spectrophotometer (NanoDrop 
technologies Inc.). cDNA was synthesized using SuperScript II Reverse 
Transcriptase (InvitrogenTM), followed by purification using the QIAquickTM PCR 
purification Kit (Qiagen). Gene expression levels were analyzed using 
quantitative Real Time PCR (qRT-PCR) with the LightCycler480® system (Roche 
Applied Science). Unless stated otherwise, gene specific primers were designed 
for this study using the LightCycler® Probe Design Software 2.0 and synthesized 
by Microsynth, Switzerland. Cxcl10; 5’-CTT GAA ATC ATC CCT GCC AC, 
and 5’-CGC TTT CAT TAA ATT CTT GAT GGT C, Ccl5; 5’-TCT CCC TAG 
AGC TGC CT, and 5’-TCC TTG AAC CAA CTT CTT CTC TG, Il6; 5’-TCC 
AGT TGC CCT CCT GGG AC, and 5’-GTG TAA AGC CTC CGA CTT C, 
Tnfa; 5’-CAT CTT CTC AAA ATT CGA GTG ACA A and 5’- TGG GAG TAG 
ACA AGG TAC AAC CC (34), Ifnb: 5’-AAC CTC ACC TAC AGG GC, and 5’-
CAT TCT GGA GCA TCT CTT GG, and Tbp: 5’-CCG TGA ATC TTG GCT 
TA AAC and 5’-TCC AGT ACT GAA AAT CAA CGA. For amplification, the 
LightCycler® FastStart DNA Master SYBR Green I kit (Roche Applied Science) 
was used. The relative gene expression levels were quantified in duplicate for 
each sample in comparison to the Tbp reference gene. Analysis and acquisition of 
real time data was executed by the LightCycler software 1.5 (Roche Applied 
Science) and Qbase software (Biogazelle) using the 2-ΔΔCT method.  
 
Analysis of cytokines and chemokines by ELISA 
Supernatants from the infection experiments were analyzed in duplicate by 
ELISA. CXCL10, CCL5, and TNFα kits were purchased from R&D systems, IL6 
(ebioscience) and IFNβ (PBL, Interferon Source) and were read on a Synergy™ 
HT Multi-Mode Plate Reader (Biotek Instruments, Switzerland). Results were 
expressed as the concentration of secreted protein above the unstimulated BMMφ 
control. 
Nucleic acid extraction and LRV1 detection in Leishmania promastigotes 
Parasites in PBS were lysed with 10% Sarcosyl (Sigma-Aldrich®), and treated 
with bovine pancreas derived RNAse (ssRNAse-Roche) and Proteinase K 
(Roche) for 2 hours at 37°C. Nucleic acids were extracted using 
Biophenol/chloroform/Isoamyl alcohol (Biosolve), precipitated with 3M sodium 
acetate in 75% ethanol, and resuspended in TE. Total RNA was extracted using 
TRIzol® reagent (Invitrogen ™). Where required, nucleic acids were treated with 
RQ1 DNAse (Promega), and/ or RNAse III (New England BioLabs) according to 
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manufacturer’s instructions. Nucleic extracts were quantified using ND-100™ 
and electrophoresed on 1% agarose gels with Lambda DNA/EcoR1 + HindIII 
(Promega) as a marker.  For purification of LRV1 dsRNA the 5.3 kb band was gel 
excised, purified by phenol/chloroform, and resuspended in LAL (endotoxin-free) 
reagent water (Promega). Reverse transcription of RNA into cDNA was 
performed as previously mentioned. qRT-PCR amplifications used LRV1 specific 
primers: 5’-CTGACTGGACGGGGGGTAAT-3’ and 5’-
CAAAACACTCCCTTACGC-3’ and Kmp11 specific primers: 5’-
GCCTGGATGAGGAGTTCAACA-3’ and 5’-GTGCTCCTTCATCTCGGG-3’ 
as described previously. Amplified DNA was excised from the gel, purified and 
sent to Fasteris SA for sequencing. The sequence homology of the LRV PCR was 
compared to reference sequences using Bioedit Software (Ibis Biosciences). 
PCR amplifications were performed as follows: 500 C for 2 min and 950C for 10 
sec then followed by 40 cycles of 950 C for 15 sec, 600 C for 1min.   The LRV1-4 
primers used were SMB2472/2473 set A (5’-GCATACCGTTTTGAGTGGAC 
and 5’-GTTTCAATCATTGGCTGACA respectively) or SMB3850/3851 set B 
(5’-TGTTACTTACCCTACGACTC and 5’-TGTGTAAGAAGTCAACT, 
respectively). Controls containing the same amount of RNA but lacking reverse 
transcriptase or template were used to rule out DNA or other contamination. 
Mouse infection and parasite quantification 
3 x 106 parasites of L.g.M-(Lg17), L.g.M5313(M+), L.g.M4147-LRVhigh, 
L.g.M4147-LRVneg were infected into the base of the hind footpads. Footpad 
swelling was measured weekly post infection using a Vernier caliper. For 
experiments with the L.g.M5313 strains parasites were quantified using the 
standard curve real time PCR quantification method using Leishmania Kmp11 
specific primers on cDNA reverse transcribed from total RNA extracted from 
footpad lysates. Infection in vivo with luciferase expressing parasites L.g.M4147 
(LRVhigh, and LRVneg) was analyzed with the In Vivo Imaging System (IVIS 
Lumina II, Xenogen) at the Cellular Imaging Facility (CIF, University of 
Lausanne). Mice were injected intra-peritoneally with 150 mg/kg D-luciferin 
(Xenogen) 10 min before imaging, anesthetized with isofluorane during imaging 
and the photons emitted from mice was quantified using the LivingImage version 
3.2 software (Caliper Life Science). Parasite burden was expressed as photons per 
second emitted from L.g.M4147 infected mice footpad lesions normalized against 
the background fluorescence of uninfected mice.  
 
Statistical test 
All experiments had statistical significance determined at p≤0.05, or p≤0.01 using 
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Fig. S1: Secretion of cytokines and chemokines by macrophages following L.g.M+ 
infection requires internalization, and endosomal recognition of an RNA motif by the 
TRIF-dependant TLR signaling pathway. Secreted cytokine and chemokine proteins were 
determined in macrophages infected 1:10 with L.g. parasites for 6 hours. Protein secretion 
levels were compared in wild-type, untreated C57BL/6 macrophages versus those 
pretreated with either chloroquine (20µM, 2 hours), or cytochalasin D (40µM, 1 hour) (A) 
or compared, to MyD88-/-, and TRIFDLPS2 macrophages (B). LPS and/or Poly I:C at 
200ng/ml, and 8µg/ml respectively were included. Data reflects at least 3 independent 
experiments, with mean ± SD protein concentration expressed above an unstimulated 
control, and statistical significance determined at (*) ρ≤0.05, and (**) ρ≤0.01. 
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Fig. S2: Macrophages recognize a nucleic-acid-derived motif present in L.g. M+ 
parasites. BALB/c macrophages were treated with ssRNAse treated nucleic acids 
(5µg/ml) isolated by phenol/chloroform from Leishmania parasites or with ssRNAse and 
DNAse digested for 6 hours. Included within these experiments were controls of calf 
thymus DNA (5µg/ml), Poly I:C (2µg/ml), CpG (2µM), and LPS (100ng/ml). Data 
reflects at least 2 independent experiments, with mean ± SD protein concentration 
expressed above unstimulated control. n.i denotes not induced. 
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Fig. S3: Quality control and purification of LRV1 dsRNA from L.g.M5313 (M+). 
(A) Genomic DNA (gDNA) and ∼ 5.3kb LRV1 dsRNA bands were visualized, 
and extracted from a 1% agarose gel, following ssRNAse treated total nucleic 
acids from stationary phase promastigotes of L.g. M+ (Lg13), L.g.M- (Lg17) and 
L.g.M5313(M+). The nucleic acids were extracted by phenol-chloroform, reverse 
transcribed, amplified by PCR using LRV1 specific primers and LRV1 specific 
products were visualized on a 1% agarose gel with the Log2 molecular marker. 
(B) Purity of the gel extracted ∼5.3 kb band corresponding to LRV1 dsRNA was 
confirmed on a 1% agarose gel; HindIII: Lambda DNA/EcoRI + HindIII 
molecular weight marker, and 2 log following purification by phenol-chloroform. 
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Fig. S4:   Determination of the presence or the absence of LRV1-4 virus in 
L.g.M4147 and in two independent clones of L.g.M4147-LRVhigh and isogenic 
virus-free derivative L.g.M4147-LRVneg. (A) ssRNAse treated nucleic acids were 
treated with DNAse and the presence of the 5.3 kb LRV1 dsRNA band visualized 
by gel electrophoresis. Nucleic acids were separated on 1% agarose gels; HindIII: 
Lambda DNA/EcoRI + HindIII marker. (B) LRV1 virus relative quantification by 
qRT-PCR using Kmp11 as a reference gene; significance determined comparing 
relative LRV1 levels between L.g.M5313(M+) L.g.M-(Lg17), L.g.M4147LRVhigh 
and L.g.M4147LRVneg. (C) Analysis of two lines of L. guyanensis M4147 
(L.g.M4147LRVhigh) and its isogenic virus-free derivative (L.g.M4147LRVneg). 
RT-PCR reactions were performed with LRV1-4 set A or set B; M, molecular 
size marker. n.d denotes not detected. 





Fig. S5: TLR3-/- mice infected with L.g.M4147-LRVhigh parasites have less 
disease pathology when compared with WT C57BL/6. Footpads of mice (n≥ 5) 
were infected with 3x106 parasites. (A) Footpad swelling, and (B) parasite burden 
were determined at 4 weeks post infection. Parasite burden was determined using 
relative luminescence. Results are expressed as mean ± SEM of all mice infected 
per group, with statistical significance at * p≤ 0.05, and ** p≤ 0.01.  	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Table S1. Infection rates of macrophages with Leishmania parasites and number 
of parasites per infected macrophages at 6 hrs post-infection. Macrophages 
immobilized onto a 6 well microscope culture slide were infected 1:10 with 
stationary phase Leishmania promastigotes for 6 hrs, and stained with Diff-Quick. 
The percent infection and number of parasites per infected cell of 750 counted 
macrophages was calculated. Results are expressed as mean ± standard deviation 
of 3 different microscope fields of view. 
 
 
 Infection rate 
(%) 
No. parasites per infected 
macrophages 
Leishmania parasites infected into C57BL/6 macrophages 
L.g.M- Clone Lg03 88.04 ± 5.03 5.90 ± 2.39 
 Clone Lg17 92.15 ± 2.10 7.10 ± 0.88 
L.g.M+ Clone Lg13 93.83 ± 4.60 7.63 ± 3.06 
 Clone Lg21 88.77 ± 8.28 6.72 ± 1.85 
 M5313 94.93 ± 4.30 10.24 ± 6.22 
L.major LV39 93.67 ± 3.94 6.51 ± 1.89 
L.g. M4147LRVhigh 94.87 ± 2.10 5.75 ± 1.43 
 M4147LRVneg 93.3 ± 3.05 4.71 ± 1.17 
Macrophages infected with L.g.M5313 (M+) 
C57BL/6 (Wildtype) 90.46 ± 7.11 7.6 ± 3.0 
TLR3-/- 88.66 ± 1.44 5.6 ± 2.5 
TLR7-/- 88.64 ± 5.71 5.9 ± 2.6 
TLR9-/- 89.49 ± 6.97 8.1 ± 3.0 
TRIFΔLPS2 91.44 ± 2.95 6.3 ± 1.7 
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